NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
ALERT — April to June 2026

 

SMSF trustees should review suspended or delisted holdings before 30 June 2026. Realising these positions will crystallise capital losses (usable against future gains) and simplify fund portfolios ahead of the Division 296 reset.

 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ELANOR INVESTORS GROUP (ENN)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of ENN: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Sydney
Level 4, 44 Martin Place Sydney NSW 2000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000ENN1
Address: Level 5, 255 George Street, Sydney NSW 2000
Tel:  +61 (0)2 9239 8400Fax: +61 (0)2 9239 8411

Date first listed: 11/07/2014

Sector: Consumer Services Industry Group: XDJ
Activities: Owning real estate backed operating businesses and managing real estate investment funds and syndicates on behalf of third party investors

News & Events

Expand this box to read and print

The suspension of trading in the securities of Elanor Investors Group will be lifted from the commencement of trading on 11 June 2026 following the release by ENN of a pro forma statement of financial position as at 31 December 2025 and a quarterly activity report and Appendix 4C quarterly cash flow report for the quarter ended 31 March 2026.

10/06/2026

The company will hold an Investor Briefing Conference Call on 11 June 2026 at 9.00am AEST, discussing strategy, financial position, and outlook before trading reinstatement. Webcast available via https://webcast.openbriefing.com/enn-mu-2026/. Dial-in details: 02 9133 7136 or 1800 216 026, Conference ID: 36631.

10/06/2026

The company corrects an error in its pro forma balance sheet for the Consolidated Group as of 31 December 2025, noted in the "ASX Reinstatement" announcement. The Consolidated NTA figures have been amended to: Dec-25A¹ 131.8m and Dec-25PF 152.7m. Additional clarifications on the preparation basis and calculation metrics reflecting ENN Securityholder interests have been included. An updated Pro Forma Balance Sheet replaces the prior version; investors should refer to this revised document. Other details remain unchanged.

09/06/2026

The company releases a letter to security holders stating that securities will resume trading on the ASX on June 11, 2026, after completing a $125 million recapitalisation. This transition supports a capital-light funds management model, emphasizing efficiency and scalability. With $1.9 billion in assets, Elanor plans disciplined growth in Australia and New Zealand. Distributions are suspended until financial conditions improve, aiming for long-term value creation.

09/06/2026

The company releases its quarterly activities/appendix 4C cash flow report as well as its Market update Presentation.

09/06/2026

The company announces ASX reinstatement on 11 June 2026 after meeting conditions, including a pro forma financial statement. Quarterly activity and cash flow reports will be provided, with an investor briefing scheduled.

09/06/2026

The company advises that it has adopted an updated Securities Trading Policy, effective 2 June 2026.

03/06/2026

The company releases its notice regarding unquoted securities.

01/06/2026

The company has provided a market update regarding key developments including the acquisition of Firmus Capital and the recommencement of trading on the ASX. The acquisition, initially set for completion, has been stalled due to delays in regulatory approvals, leading to a mutual agreement to not extend the transaction's deadline. Elanor and Rockworth will continue exploring future acquisition opportunities. Additionally, Elanor is seeking ASX approval to resume trading in ENN securities.

29/05/2026

The company announces Ernst & Young as its new auditor, effective for the financial year ending 30 June 2026, replacing PricewaterhouseCoopers. The change follows an audit tender process and requires securityholder ratification at the upcoming Annual General Meeting.

21/05/2026

The company received an ASX waiver regarding Listing Rule 14.7 for issuing stapled securities as part of its recapitalisation with Rockworth Capital Partners, notably for acquiring Firmus Capital, which manages around S$658 million in assets. The waiver allows the Consideration Securities to be issued to Su Kiat Lim or Laville within 2 months post the initial extension date of 10 May 2026, subject to conditions. Elanor sought the waiver due to pending regulatory approvals crucial for completing the acquisition.

21/05/2026

The company lodges its notice of cessation of securities.

23/04/2026

Securities of the company suspended over three months must submit outstanding periodic reports by deadlines; failure to meet one- or two-year deadlines results in removal from the official list, effective the next trading day.

17/04/2026

The company completed a $125 million balance sheet recapitalisation with Rockworth Capital Partners on April 17, 2026. This included a $70 million secured debt facility, $55 million in perpetual notes, and $30 million in unlisted warrants. Proceeds were used to fully repay existing facilities and enhance working capital. The Group is finalizing the acquisition of Firmus Capital, pending approvals. Following the HY26 results release, Elanor seeks ASX approval for trading resumption and has received a new financial services license from ASIC.

17/04/2026

The company releases its financial statements for December 2025.

09/04/2026

The company releases its half yearly report and accounts.

09/04/2026

The company releases the results of its annual general meeting.

09/04/2026

The company releases its 2025 AGM addresses and presentation.

09/04/2026

The company achieved a significant milestone by executing recapitalisation documentation with Rockworth for $125 million, stabilising its balance sheet. Upcoming HY26 financial results will be released, and trading discussions with the ASX have begun.

07/04/2026

The company lodges the following for June 2025: appendix 4E, annual report, financial statements, appendix 4G, and corporate governance statement.

10/03/2026

The company will hold its 2025 annual general meeting at 2.00pm (Sydney time) on 9 April 2026 at The Hart Room, Level 1, Amora Hotel Jamison Sydney, 11 Jamison Street, Sydney, NSW 2000.

06/03/2026

The company releases its interim financial results for 2024.

27/02/2026

The company releases its interim financial report for December 2024.

27/02/2026

The company has achieved key milestones in its business reset, securing securityholder approval for recapitalisation with Rockworth and acquiring Firmus Capital. A $125 million refinancing strategy aims to stabilize Elanor's balance sheet, bolstered by asset sales like the $13 million co-investment from the Elanor Wildlife Park Fund. Approximately $21 million of the senior secured facility has been repaid, with leadership changes and enhanced corporate governance on the horizon. Financial results for HY25 and FY25 will be released soon.

10/02/2026

The company releases the results of its extraordinary general meeting for 10 February 2026.

10/02/2026

The company releases its 2026 EGM Presentation as well as its Chair's Address.

10/02/2026

The company has terminated the investment and property management agreements for Elanor Commercial Property Fund after securityholders appointed Evolution Trustees Limited as the new Responsible Entity, accepting reduced compensation of $8.5 million.

04/02/2026

LDR convened a general meeting for ECF securityholders on 30 January 2026; results announced by Elanor Funds Management in compliance with ASX rules.

30/01/2026

Securities of the company have been suspended for over three months due to failure in lodging periodic reports as per Listing Rule 17.5. The company faces a one-year deadline to submit the oldest report and a two-year deadline for resuming trading; failure to comply results in removal from the official list.

22/01/2026

The company will hold its extraordinary general meeting on 10 February 2026 at 12.00pm (Sydney time) at The Hart Room, Level 1, Amora Hotel Jamison Sydney, 11 Jamison Street, Sydney NSW 2000.

06/01/2026

The company has expanded its strategic alliance with Rockworth Capital Partners, extending the sunset date to January 9, 2026, for meeting notices. The EGM is expected in early February 2026, while FY25 results and AGM preparations are underway, with document lodgements ongoing.

24/12/2025

The company has arranged for the transition of Elanor Commercial Property Fund management to Lederer Group, following a proposal to remove Elanor Funds Management as the Responsible Entity. Elanor agrees to a reduced termination compensation of $8.5 million, which will benefit ECF investors through lower fees and improved alignment.

24/12/2025

The company lodges its notice of cessation of securities.

28/11/2025

The company updates on its strategic alliance with Rockworth Capital Partners, which plans a $125 million investment to recapitalize Elanor. The Firmus business acquisition is also underway, pending regulatory and securityholder approval. Extensions for the EGM and transaction completion dates have been set. Additionally, Elanor is finalizing HY25 financial results and plans to lift its securities suspension post-approval of the Rockworth deal.

24/11/2025

The company releases the results of its annual general meeting for 2025.

19/11/2025

The company releases its 2024 AGM addresses as well as its presentation.

19/11/2025

The company releases its notice of cessation of securities.

22/10/2025

The company has postponed its 2024 AGM, originally scheduled for 28 November 2024. The FY24 Annual Report is now released. The AGM will occur on 19 November 2025 at 1:30pm at The Boyd Room, Level 2, Amora Hotel Jamison Sydney, 11 Jamison Street, Sydney NSW 2000. A new Notice and Explanatory Statement have replaced the initial documents. Proxy voting resumes today, with prior votes canceled. All updated details are available in the attached documents.

17/10/2025

The company lodges its annual report for 30 June 2024, its appendix 4G, and corporate governance statement for 2024.

17/10/2025

Securities of the company have been suspended for over three months. A table details the unlodged periodic reports per Listing Rule 17.5, their one-year deadlines, and the two-year deadline for resuming trading. Failure to meet these deadlines results in removal from the official list after the deadline.

15/10/2025

The company has received a waiver from ASX regarding Listing Rule 10.13.5 for its collaboration with Rockworth Capital to secure up to A$125 million for business recapitalization. ASX will allow the issuance of Consideration Securities to Su Kiat Lim or Laville within three months after the securityholder meetings, instead of the usual one-month limit. This extension is necessary due to pending regulatory approvals for acquiring Firmus Capital, ensuring securityholders are informed about the dilutive impact before granting approval.

26/09/2025

The company is ending its partnership with Challenger Limited, reclaiming 12,377,083 stapled securities from Fidante Partners. This involves a selective buy-back of Elanor Investment Fund units and a reduction of shares in Elanor Investors Limited, totaling about 61% of Fidante's stakes. Securityholders approved the clawback on 30 June 2023, adhering to ASIC relief, reducing Fidante's ENN holdings from 13.3% to 5.7%. Completion is expected by 16 October 2025, with future clawbacks planned.

19/09/2025

The Panel has declined to conduct proceedings on an application from Elanor Funds Management Limited regarding the Elanor Commercial Property Fund amid an off-market takeover bid by LDR Assets Pty Ltd. EFM claimed the bidder's statement by Lederer had material deficiencies. However, the Panel observed that EFM and Lederer had negotiated amendments addressing most disclosure concerns. Lederer plans to lodge a revised bidder's statement. The Panel found no reasonable prospect for declaring unacceptable circumstances, leading to its decision not to proceed.

10/09/2025

The Panel received an application from Elanor Funds Management Limited concerning Elanor Commercial Property Fund amid an off-market takeover bid by LDR Assets Pty Ltd, offering $0.70 per ECF security. An independent board committee represents ECF. Lederer, which controls 27.54% of ECF, submitted a bidder's statement indicating intentions to replace the responsible entity if it acquires over 50% of securities. The applicant alleges material deficiencies in the bidder's statement and seeks orders for disclosures and a replacement statement to address these deficiencies.

03/09/2025

The company will conduct an Investor Briefing on 03 September 2025 at 10.00am AEST, covering: expansion of alliance with Rockworth Capital Partners; off-market takeover offer for the Elanor Commercial Property Fund; corporate governance enhancements; business stabilisation and asset realisation program; and FY24 audited financial statements lodgement. Webcast link: https://webcast.openbriefing.com/enn-mu-2025/. Dial in details: 1800 954 501, Conference ID: 10049938.

02/09/2025

The company updates on key developments: expansion of the strategic alliance with Rockworth Capital Partners, an off-market takeover offer for the Elanor Commercial Property Fund, enhancements in corporate governance, a business stabilization and asset realization program, and the FY24 audited financial statements lodgement.

01/09/2025

The company lodges its annual financial report for 30 June 2024.

29/08/2025

The company responded to Lederer Group's unsolicited takeover offer for the Elanor Commercial Property Fund, proposing 70 cents per security. An Independent Board Committee was formed to protect securityholders' interests, while Elanor continues its business stabilization and expansion plans, including a $125 million investment with Rockworth Capital Partners.

13/08/2025

The company has announced that the Lederer Group plans to make an unsolicited off-market takeover offer for all stapled securities in the Elanor Commercial Property Fund. The Board is currently evaluating its response to the proposed Lederer Offer.

04/08/2025

The company updates on capital recapitalisation and strategic alliance with Rockworth Capital Partners. Key developments include a $125 million investment from Rockworth to stabilise the balance sheet, acquisition of Firmus Capital, and termination of the Challenger Life Mandate. The investment enhances growth prospects in Australia and Asia.

28/07/2025

Securities of the company remain suspended for over three months. A table includes unlodged periodic reports per Listing Rule 17.5, the one-year deadline for the oldest report, and the two-year deadline for trading resumption plans. Failure to meet these deadlines leads to removal from the official list after the deadline.

16/07/2025

The company is stabilizing its balance sheet and managing working capital for positive investor outcomes. Cost management is driving sustainable reductions in overheads and better cash flow. Asset divestments over $300 million, including Gladstone Square sales, will finalize by July 2025. The Group is negotiating amended debt repayments for the Keyview facility due to breaches and enhancing corporate governance with an independent trustee board and a proposal for changing the Elanor Investment Fund's responsible entity.

01/07/2025

The company's securities have been inactive for over three months. The one-year deadline for the oldest report, and the two-year deadline to restore trading. Failure to meet these deadlines results in removal from the official list after a specified date.

09/04/2025

The company reports that over 90% of Noteholders approved a Special Resolution regarding its $40 million Corporate Notes, a significant step in its balance sheet stabilisation strategy. The resolution includes increasing the Notes' coupon to 15% annually, granting security post-Keyview repayment, simplifying financial covenants, allowing easier early redemption, and extending the maturity of certain Notes. The Group is focused on balance sheet stability and asset realisation, with uncertainties surrounding Keyview's support. FY24 results are being finalised, with the AGM date to be confirmed.

04/04/2025

The company is stabilising its balance sheet and managing working capital through an asset realisation program. It negotiated amendments to its $40 million Corporate Notes, implementing a 90-day standstill. A Circulating Resolution proposes a 15% coupon rate, simplified covenants, and extended maturities, with ongoing stakeholder engagement to support de-leveraging.

26/03/2025

The company is stabilizing operations through de-leveraging, simplifying capital structure, and cost control. An asset realization program has generated about $225 million in transactions since July 2024, with over $250 million in due diligence underway. The Group aims to finalize FY24 and HY25 financial statements while negotiating the sale of co-investment holdings. After selling Manning Mall and Northway Plaza, Gladstone Square is now listed, marking the completion of the Elanor Property Income Fund's asset realization. Hotel assets worth $53.5 million were transacted, with further sales planned to reduce gearing. Corporate costs are minimized, and negotiations with financiers are ongoing. Elanor is managing Challenger Life Company's commercial real estate portfolio, providing financial stability updates, while exploring value-maximizing options for securityholders. Regular market updates will continue.

12/03/2025

The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day.

22/01/2025

The company cancels its release of its notice of dividend/distribution.

27/12/2024

The company refinanced its senior secured debt facility with a $85 million debt bridging facility from Keyview Financial Group. The Group is negotiating revised terms of its unsecured corporate notes, with support from Noteholders. The Group will release FY24 financial results and AGM, and request ASX to lift securities suspension.

23/12/2024

The company lodges its notice of dividend/distribution.

23/12/2024

The company has completed its Challenger Life Company review and will continue providing asset management services. The group's asset realisation program has transacted $190 million since July 2024, with remaining assets expected to be sold. Elanor's balance sheet stabilisation involves refinanzing its senior secured debt facility and restructuring its unsecured corporate notes. The Group will issue a Circulating Resolution for approval, release FY24 financial results, and request ASX to lift the suspension of its securities.

05/12/2024

The company has postponed its AGM to a later date due to ongoing activities to finalize its financial statements and Annual Report. The Group will announce the new date and time once finalized.

15/11/2024

The company has refinanced its senior secured debt facility with a $85 million debt bridging facility from Keyview Financial Group, releasing over $100 million of its balance sheet capital over 18 months. The company is currently in default on its Unsecured Corporate Notes. Elanor is awaiting finalization of its FY24 financial results and AGM, and is considering various options to stabilize its financial position.

01/11/2024

The Annual General Meeting is scheduled for Thursday, 28 November 2024, at 10 am in person at The Hart Room, Level 1, Amora Hotel Jamison Sydney, 11 Jamison Street, Sydney NSW 2000.

28/10/2024

The company is focusing on strengthening its balance sheet, simplifying its business, and optimizing value for its securityholders. The Group completed a sale of its 12.6% interest in ECF, reducing its senior secured debt facility by $15 million. They have also refinancing their existing debt, accepting credit from Keyview Financial Group for a $125 million facility. The Group is working to remedy a potential default by 31 October 2024. The Group will finalize its Appendix 4E and Annual Report.

11/10/2024

Sale of co-investment stake in ECF for approximately $23.9 million, with proceeds used to reduce gearing and provide working capital. Other capital management initiatives and asset realisation programs underway. Focus on the retail, office, healthcare and industrial sectors. Exit from the hotels, tourism and leisure sector. Orderly asset realisation programs in progress to return capital across five Elanor managed funds. Executing cost management initiatives.

09/09/2024

The securities of Elanor Investors Group were suspended from quotation at ENN's request on 23 August 2024, pending the release of an announcement regarding its financial position. Since its securities were suspended, ENN has not lodged its Preliminary Final Report. As a consequence, ENN's securities will continue to be suspended from quotation by ASX under Listing Rule 17.5, until such time as ENN lodges its Preliminary Final Report and that it is otherwise appropriate for ENN's securities to be reinstated to quotation.

06/09/2024

The company has made significant progress in stabilizing and maintaining its financial position, following its request for the voluntary suspension of its securities. The Group expects to provide an update to the market and lodge its Appendix 4E Preliminary Final Report.

06/09/2024

The company lodges its notice of cessation of securities.

02/09/2024

The company releases a notice of cancelation of dividend/distribution.

23/08/2024

The securities of Elanor Investors Group will be suspended from quotation immediately under Listing Rule 17.2, at the request of ENN, pending the release of an announcement regarding its financial position.

23/08/2024

listed entity carried for record purposes only

14/07/2014

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

I can't express how devistated I am after losing my retirement savings to this group 

23/06/2025 19:33:18

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    26/06/2026Anthony Fehon400,000$0.059$23,738
    17/06/2026Karyn Baylis100,000$0.070$7,000
    17/06/2026Anthony Fehon231,088$0.056$13,027
    12/06/2026Katherine Ostin2,085,714$0.053$109,824
    12/06/2026Ian Mackie172,069$0.058$9,980

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Ian MackieChairman25/08/2023
    Anthony FehonManaging Director20/08/2019
    David McNamaraCEO22/06/2026
    Karyn BaylisNon Exec Director01/11/2021
    Katherine OstinNon Exec Director01/01/2024
    Symon SimmonsCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Su Kiat LimNon Exec Director01/10/202102/06/2026
    Nigel AmpherlawNon Exec Director13/06/201423/09/2024
    Glenn WillisManaging Director, CEO01/05/201409/09/2024
    Paul SiviourCOO08/09/201409/09/2024
    Victor RodriguezNon Exec Director07/07/202303/09/2024
    Paul BedbrookChairman13/06/201431/12/2023
    Lim Kin SongNon Exec Director30/05/201925/01/2021
    Bill MossNon Exec Director01/05/201417/09/2019

    Date of first appointment, title may have changed.